Top of the morning to you, and a fine one it is. ‘Tis easy to ignore the gloomy skies hovering over the Pharmalot campus, since we are reciting one of our favorite mantras: Every brand new day should be unwrapped like a precious gift (hat tip to the Morning Mayor). So we will reach for another cup of stimulation — we are trying caramel cream today, for those tracking this sort of thing — you can tug on the ribbon and explore the tidbits below. Have a smashing day and, of course, do keep in touch …

Which drug maker is most vulnerable to the aftermath of Hurricane Maria in Puerto Rico? Well, AbbVie (ABBV) derives about 72 percent of its U.S. prescription drugs sales from products made, in whole or in part, on the island, according to Sector & Sovereign Research. Amgen (AMGN) is a close second at 67 percent. Not surprisingly, many companies are still running below capacity, according to STAT.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy